Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $228.0 million.

  • Gossamer Bio's Shares Outstanding (Weighted Average) rose 72.25% to $228.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.0 million, marking a year-over-year increase of 72.25%. This contributed to the annual value of $226.2 million for FY2024, which is 4822.8% up from last year.
  • Latest data reveals that Gossamer Bio reported Shares Outstanding (Weighted Average) of $228.0 million as of Q3 2025, which was up 72.25% from $227.3 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Shares Outstanding (Weighted Average) peaked at $228.0 million during Q3 2025, and registered a low of $75.9 million during Q1 2022.
  • In the last 4 years, Gossamer Bio's Shares Outstanding (Weighted Average) had a median value of $192.9 million in 2023 and averaged $163.4 million.
  • In the last 5 years, Gossamer Bio's Shares Outstanding (Weighted Average) skyrocketed by 13794.09% in 2024 and then skyrocketed by 46.6% in 2025.
  • Over the past 4 years, Gossamer Bio's Shares Outstanding (Weighted Average) (Quarter) stood at $84.6 million in 2022, then soared by 80.46% to $152.6 million in 2023, then soared by 48.23% to $226.2 million in 2024, then rose by 0.78% to $228.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $228.0 million for Q3 2025, versus $227.3 million for Q2 2025 and $226.8 million for Q1 2025.